TIA
RMD icon

Tandem Investment Advisors’s ResMed RMD Stock Holding History

Tandem Investment Advisors’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$98.1M Sell
436,912
-63,233
-13% -$15.8M 4.81% 3
2025
Q4 		$120M Sell
500,145
-5,071
-1% -$1.3M 4.49% 6
2025
Q3 		$138M Buy
505,216
+7,315
+1% +$2M 4.72% 4
2025
Q2 		$128M Sell
497,901
-7,082
-1% -$1.69M 4.5% 4
2025
Q1 		$113M Buy
504,983
+3,236
+0.6% +$755K 3.94% 8
2024
Q4 		$115M Buy
501,747
+5,087
+1% +$1.22M 4.34% 5
2024
Q3 		$121M Sell
496,660
-4,731
-0.9% -$1.06M 4.59% 2
2024
Q2 		$96M Buy
501,391
+14,590
+3% +$2.96M 3.82% 6
2024
Q1 		$96.4M Buy
486,801
+111,355
+30% +$20.4M 3.73% 7
2023
Q4 		$64.6M Sell
375,446
-14,112
-4% -$2.17M 2.58% 20
2023
Q3 		$57.6M Buy
389,558
+189,838
+95% +$34.3M 2.43% 22
2023
Q2 		$43.6M Buy
199,720
+12,979
+7% +$2.89M 1.92% 29
2023
Q1 		$40.9M Buy
186,741
+11,890
+7% +$2.58M 1.96% 25
2022
Q4 		$36.4M Buy
174,851
+18,544
+12% +$4.07M 1.88% 27
2022
Q3 		$34.1M Sell
156,307
-31,973
-17% -$7.28M 1.94% 28
2022
Q2 		$39.5M Buy
188,280
+57,067
+43% +$12.1M 2.33% 22
2022
Q1 		$31.8M Buy
131,213
+9,087
+7% +$2.2M 1.95% 26
2021
Q4 		$31.8M Buy
122,126
+10,903
+10% +$2.83M 2.07% 25
2021
Q3 		$29.3M Buy
111,223
+7,058
+7% +$1.93M 2.4% 22
2021
Q2 		$25.7M Buy
104,165
+3,839
+4% +$807K 2.2% 22
2021
Q1 		$19.5M Buy
100,326
+11,144
+12% +$2.23M 1.87% 25
2020
Q4 		$19M Buy
89,182
+7,806
+10% +$1.56M 2.04% 25
2020
Q3 		$13.9M Buy
81,376
+10,228
+14% +$1.89M 1.71% 29
2020
Q2 		$13.7M Buy
71,148
+1,150
+2% +$188K 1.84% 27
2020
Q1 		$10.3M Sell
69,998
-5,758
-8% -$917K 1.53% 31
2019
Q4 		$11.7M Sell
75,756
-18,480
-20% -$2.66M 1.97% 26
2019
Q3 		$12.7M Buy
94,236
+5,106
+6% +$669K 2.31% 24
2019
Q2 		$10.9M Buy
89,130
+2,347
+3% +$260K 2.06% 27
2019
Q1 		$9.02M Buy
86,783
+12,133
+16% +$1.25M 1.99% 28
2018
Q4 		$8.5M Buy
74,650
+5,769
+8% +$618K 2.21% 25
2018
Q3 		$7.95M Sell
68,881
-20,270
-23% -$2.22M 2.18% 25
2018
Q2 		$9.23M Sell
89,151
-1,291
-1% -$131K 2.82% 22
2018
Q1 		$8.91M Buy
90,442
+9,311
+11% +$880K 2.9% 20
2017
Q4 		$6.87M Sell
81,131
-1,196
-1% -$98.8K 2.36% 24
2017
Q3 		$6.34M Sell
82,327
-24,507
-23% -$1.87M 2.38% 24
2017
Q2 		$8.32M Buy
106,834
+5,137
+5% +$368K 3.3% 12
2017
Q1 		$7.32M Buy
101,697
+7,489
+8% +$518K 3.24% 11
2016
Q4 		$5.85M Buy
+94,208
New +$5.77M 2.82% 12

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Tandem Investment Advisors's RMD Position: Q1 2026 in Review

Tandem Investment Advisors reduced its ResMed (RMD) stake by 13% in Q1 2026, selling an estimated $15.8M and leaving 436,912 shares worth $98.1M. The position accounts for 4.81% of the portfolio, ranked #3.

Tandem Investment Advisors first reported a position in RMD in Q4 2016 and has held it in 38 quarters since. The position peaked at $138M in Q3 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Tandem Investment Advisors held 436,912 shares of ResMed worth $98.1M as of Q1 2026.
  • Tandem Investment Advisors sold 63,233 ResMed shares in Q1 2026, an estimated $15.8M.
  • ResMed made up 4.81% of Tandem Investment Advisors's portfolio in Q1 2026, its #3 holding.
  • Tandem Investment Advisors first reported a position in ResMed in Q4 2016 and has held it in 38 quarters since.
  • Tandem Investment Advisors's ResMed position peaked at $138M in Q3 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Tandem Investment Advisors's 13F filing for Q1 2026, filed 7 May 2026.